MECOM and acute myeloid leukemia: However, the fact that EVI1+ AML without 3q26 lesions are relatively rare suggests that the risk to develop a potent driver lesion like a KMT2A-MLLT3 fusion in TPO-stimulated cycling EVI1+ HSC is very low.